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ABSTRACT
Expression of viral proteins frequently includes
non-canonical decoding events (‘recoding’) during
translation. ‘2A’ oligopeptides drive one such
event, termed ‘stop-carry on’ recoding. Nascent 2A
peptides interact with the ribosomal exit tunnel to
dictate an unusual stop codon-independent termin-
ation of translation at the final Pro codon of
2A. Subsequently, translation ‘reinitiates’ on the
same codon, two individual proteins being
generated from one open reading frame. Many 2A
peptides have been identified, and they have a
conserved C-terminal motif. Little similarity is
present in the N-terminal portions of these
peptides, which might suggest that these amino
acids are not important in the 2A reaction.
However, mutagenesis indicates that identity of
the amino acid at nearly all positions of a single 2A
peptide is important for activity. Each 2A
may then represent a specific solution for position-
ing the conserved C-terminus within the
peptidyl-transferase centre to promote recoding.
Nascent 2A peptide:ribosome interactions are sug-
gested to alter ribosomal fine structure to discrim-
inate against prolyl-tRNA
Pro and promote
termination in the absence of a stop codon.
Such structural modifications may account for
our observation that replacement of the final Pro
codon of 2A with any stop codon both stalls
ribosome processivity and inhibits nascent chain
release.
INTRODUCTION
A small number of nascent peptides are known to interact
with the ribosomal exit tunnel and/or peptidyl-transferase
centre (PTC) to regulate translation of downstream
mRNA sequences (1,2). Most of these are encoded by
short upstream ORFs (uORFs) in eukaryotes, or leader
peptides in bacteria, and typically pause or stall ribosomes
in response to small molecule effectors. ‘2A’ peptides,
characterized by a C-terminal ‘-D12(V/I)ExNPGP19-’
motif (3,4), are further sequences that pause ribosomes
(5–7). However, unlike other characterized ribosome-
pausing peptides, 2As also drive a translational recoding
event, in which two separate proteins (the ‘upstream’ and
‘downstream’ products) are generated from an ORF con-
taining a 2A coding sequence, with a ‘break’ in the poly-
peptide backbone between the ﬁnal 2 amino acids, Gly
and Pro, of 2A (formally this Pro is the ﬁrst amino acid
of the downstream protein, but is an essential part of
active 2A). The 2A reaction has been termed ‘StopGo’
or ‘stop-carry on’ recoding (6,8). 2A peptides are active
when transposed into other proteins, i.e. they are autono-
mous elements, and mediate recoding in all eukaryotic
ribosomes tested. The unique activity of 2A peptides has
led to their use as tools for co-expression of two (or more)
proteins in biomedicine and biotechnology (9).
The most studied 2A peptide is found in the Aphthovirus
foot-and-mouth disease virus (FMDV). The FMDV RNA
genome contains a single, long ORF encoding a
polyprotein. 2A directs a key, primary processing event
in the resolution of the polyprotein to individual
proteins. Modelling of FMDV 2A indicated that it may
form an (amphipathic) a-helix over most of its length,
with a reverse turn at its C-terminus (5,10). This led to
the suggestion that the a-helix, in the ribosomal exit
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the peptidyl–tRNA
Gly in the PTC, disfavouring peptide
bond formation to prolyl–tRNA
Pro, while promoting
hydrolysis of the peptidyl–tRNA
Gly ester bond, thereby
generating the upstream product. Pro is the poorest
nucleophile of all proteinogenic amino acids since its sec-
ondary amino group is conformationally and sterically
constrained. It may therefore be uniquely affected by
subtle changes within the PTC. Hydrolysis of the
nascent peptidyl-2A-tRNA
Gly ester bond is catalysed by
translation terminating release factors (eRFs), despite the
presence of the Pro codon in the A-site (6). Since mutation
of this Pro codon to codons encoding several other amino
acids almost completely abrogates 2A activity (5,11), any
conformational shift in the PTC driven by 2A is suggested
to discriminate prolyl-tRNA
Pro from other aminoacyl-
tRNAs.
Sequencing of viral genomes has provided increasing
numbers of 2A sequences and this provides opportunity
to examine common features of and differences in this
family of peptides. Here, viral 2A peptides are compared
and FMDV 2A used as an exemplar for extended muta-
genesis, providing in-depth analysis of a peptide that
affects ribosomal processivity. A direct test of disturbance
to ribosome conformation driven by 2A was provided by
testing whether release factors could efﬁciently terminate
translation when Pro19 was replaced with a stop codon.
MATERIALS AND METHODS
Strains and media
Yeast strains JDY4 (ura3-D99, ade2-101, his3-D200, leu2-
D1, trp1-D99, cir
o, MATa) and JDY705 (ura3-52,
ade2-101, his3-D200, leu2-D1, trp1-D63, ubr1D::LEU2,
MATa) were grown on media indicated.
2A sequences
A set of viral 2A peptides (4) supplemented with newly
identiﬁed sequences (Supplementary Table S1) was used to
examine amino acid composition and conservation using
Excel (Microsoft) and Weblogo (12).
Constructs
[UBI-R2A-ADE2] was assembled in pRS314 (13) from
fragments encoding ubiquitin, FMDV 2A preceded by
arginine and Ade2p, [CFP-2A-PAC] in pcDNA3.1
(Invitrogen) from sequences encoding cyan ﬂuorescent
protein and puromycin acetyltransferase, each preceded
by the V5 epitope tag and separated by FMDV 2A.
Mutations were engineered into these constructs by
replacing 2A sequences with PCR products, ampliﬁed
from [UBI-R2A-ADE2], using oligonucleotides that
incorporated the mutations. An ApaI site used in
cloning corresponds to the ﬁnal 2 codons of 2A.
Mutations to these codons were introduced using frag-
ments extended to include an ApaI site, thus inserting
an extra GP dipeptide. Polymerase chain reaction (PCR)
products from which mRNAs ending with 2A sequences
were synthesized were generated from pJN141 (6) using
SP6 primer and primers incorporating nucleotides of
2A up to the codon required and mutations as necessary.
Clones were veriﬁed by sequencing.
Random mutagenesis
Mutations were incorporated into 2A amino acids Asp14
to Pro19 by amplifying a fragment from [UBI-
R2A-ADE2] using oligonucleotides CM (50-GACCTTCT
TAAGCTTGCGGGAGACGTCGAGTCCAACCCTGG
GCCCATCGATCCCATG), which contained 2% of each
non-template nucleotide at italicized positions, and adeR
(50-CATTAACGTGGTCATTGGAGTTGC). This was
combined in a second round of PCR with an overlapping
product extending from the T3 promoter upstream of
[UBI-R2A-ADE2] to the 50 portion of 2A (CMR 50-TC
CCGCAAGCTTAAGAAGGTC). The resulting product
was transformed into JDY4 with the [UBI-R2A-ADE2]
plasmid digested to remove the [UBI-R2A] coding
region, and in vivo gap-repair regenerated complete
plasmids incorporating mutations. A similar strategy
introduced mutations into sequences coding for
Leu1-Gly11. Oligonucleotides were NN (50-TCTAGAA
GGAGCATGCCAGCTGTTGAATTTTGACCTTCTTA
AGCTTGCGGGAGACGTCGAGTCCAACCC) plus
adeR and NR (50 CTGGCATGCTCCTCTAGA) plus T3.
Yeast transformations were plated onto media lacking
tryptophan and containing limited adenine as
hemisulphate (24mg/ml). All white or pigmented colonies
were picked from regions of transformation plates for
unbiased selection. Each was mixed into 150mlo f
30% v/v glycerol in a microtitre plate well and a 48-pin
tool used to spot cells onto media. A region of the plasmid
in each colony including 2A was ampliﬁed from yeast cells
and sequenced.
In vitro transcription/translation, quantiﬁcation
[CFP-2A-PAC] and derivatives were analysed in rabbit
reticulocyte lysate-coupled transcription-translation reac-
tions (Promega), and quantiﬁed (3). Capped mRNAs
(Figure 5B and C) were generated using SP6 RNA poly-
merase (Promega), and translated in wheat germ lysate
(Promega). Translation products were resolved on
Tris–Tricine (14), or NuPAGE (Invitrogen) sodium
dodecyl sulphate–polyacrylamide gel electrophoresis
(SDS–PAGE) gels, images captured and analysed on a
Typhoon Trio scanner with ImageQuant (GE Healthcare).
RESULTS
Reporters of 2A activity
To facilitate analysis of 2A and mutant versions of it, two
artiﬁcial polyprotein reporters were used. The ﬁrst
comprised cyan ﬂuorescent protein-2A-puromycin
acetyltransferase ([CFP-2A-PAC]) (Figure 1A) and tem-
plates encoding this were used in in vitro translation reac-
tions with [35-S] methionine, from which the products
were quantiﬁed after resolution on SDS–PAGE gels.
The second permitted assessment of 2A activity in vivo
in yeast (Saccharomyces cerevisiae), where we have
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ubiquitin–arginine-2A-phosphoribosylaminoimidazole
(AIR) carboxylase ([UBI-R2A-ADE2]) (Figure 2A).
Ubiquitin-dependent proteases cleave ubiquitin fusion
proteins, and thus ubiquitin will be removed from
[UBI-R2A-ADE2] leaving Arg as a new N-terminal
amino acid. An N-terminal Arg targets a protein for deg-
radation through the N-end rule pathway (16), and stable
Ade2p is only generated from this reporter if the
2A reaction has freed it from the N-terminal Arg. Thus,
expression of [UBI-R2A-ADE2] in otherwise ade2 yeast
leads to growth on plates lacking adenine, while expres-
sion of a variant containing the non-functional Pro17 to
Ala 2A mutant (3) does not (Figure 2B). N-end rule
pathway-deﬁcient cells [lacking the E3-ubiquitin ligase
Ubr1p (17)] expressing this mutant grow on media
lacking adenine, conﬁrming that [R2A-ADE2] is
degraded through the N-end rule pathway.
Yeast cells lacking Ade2p accumulate red derivatives of
the enzyme’s substrate, AIR (18) and colonies of ade2 cells
expressing the Pro17 to Ala mutant of [UBI-R2A-ADE2]
were pigmented on plates containing limited amounts of
adenine (Figure 2B). Further, [UBI-R2A-ADE2] allowed
discrimination between 2A mutants with different
activities. Cells expressing [UBI-R2A-ADE2] variants
containing previously characterized partially active
2A mutants (3) displayed a range of colours, the most
active mutants being pale pink and those with less
activity being more pigmented (Figure 2C). The relative
activity of the mutants was slightly different in the context
of [UBI-R2A-ADE2] than in in vitro translations [compare
colony colours in Figure 2C with the % activity ﬁgures
below, which are from (3)]. These differences may be due
to translation by yeast, rather than wheat or rabbit
ribosomes.
2A is largely intolerant to sequence alteration
Previous mutagenesis of 2A has largely been to conserved
C-terminal residues, and individual positions within the
peptide have not been substituted with a wide range of
other amino acids. To examine sequence constraints
within 2A, systematic Pro-, Gly- and Ala-scanning as
well as random mutagenesis were carried out on FMDV
2A. Pro and Gly inﬂuence secondary structure, constrain-
ing or providing high ﬂexibility to peptide chains, respect-
ively. In contrast, Ala has little inﬂuence on secondary
structure. Complete sets of mutants with Pro, Gly and
Ala substituted for individual amino acids in 2A were
generated in [CFP-2A-PAC], and analysed by in vitro
translation (Figure 1B–E). The Gly and a subset of the
Pro substitution mutants were also tested in vivo in the
context of [UBI-R2A-ADE2].
Qualitatively the in vitro and in vivo assays provided
similar results, Gly and, where tested, Pro substitution
mutants showing the least activity in vitro yielding
AC
BD
E
Figure 1. Scanning mutagenesis of FMDV 2A. (A) The [CFP-2A-PAC] reporter polyprotein comprises cyan ﬂuorescent protein and puromycin
acetyltransferase, each preceded by a single V5 epitope tag and separated by FMDV 2A. The separation point of the nascent chain driven by the
2A reaction is indicated with a downwards arrow. (B–E) Activities of [CFP-2A-PAC] variants containing (B, C) Ala (D) Gly or (E) Pro substituted
for the individual amino acids of 2A indicated, and the wild-type (wt). (B) Coupled reticulocyte lysate transcription–translation reactions assembled
with [35-S] methionine were programmed with constructs encoding [CFP-2A-PAC] or Ala substitutions at the positions indicated, resolved on an
SDS–PAGE gel. M, markers in kDa. E, up and down refer to the complete translation product [CFP-2A-PAC], and the upstream [CFP-2A] and
downstream [PAC] products of the 2A reaction, respectively. (C–E) Three independent sets of experiments as in (B) were quantiﬁed for each set of
substitutions. Average activity (% of ribosomes releasing the upstream product)±one standard deviation is shown.
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Figure 1D and E with Figure 2D). Substitutions at most
positions of 2A for Ala, Gly or Pro had similar effects,
and, in most cases, activity was more affected by substi-
tutions to amino acids towards the C-terminus of 2A than
those within its N-terminal portion. Only substitutions of
Leu1 or Leu2 were neutral, substitutions at positions 3–6
reduced activity between a half to one-third of wild type
(though Pro at position 5 had very low activity), while
substitutions to amino acids 7–19 had, in general, low
activity. Exceptions were Ala at positions 8 and 15,
which were around 50% active in vitro and Pro at
position 15, which yielded nearly 100% activity in vitro
and persistently white colonies in vivo. Ala is not found
at position 8 or 15 in known viral 2A peptides, although
Pro is observed at residue 15 in Duck hepatitis virus
(DHV-1) and in a small number of FMDV strains
(Figure 4A; Supplementary Table S1 and data not
shown). Replacement of position 15 with Gly, in
contrast to Ala or Pro, yielded low activity. Flexibility
provided to the nascent chain by introduction of Gly at
this position may adversely affect its ability to adopt a
conformation conducive to the 2A reaction.
Screens for random mutants within 2A were performed
using the [UBI-R2A-ADE2] reporter polyprotein (see
‘Materials and Methods’ section). This provided 52
unique single amino acid alterations to 2A, and this col-
lection was supplemented with site-directed mutants that
provided alterations at positions where no mutants had
been generated in the screens, and also broadened the
spectrum of substitutions represented at some other pos-
itions. Including mutants generated in the scanning muta-
genesis, 92 single amino acid changes to 2A were created
within [UBI-R2A-ADE2]. Mutants were assigned to four
activity categories: white (active), pale pink, dark pink and
red (inactive) (summarized in Figure 3). Only 15 mutants
generated sufﬁciently high Ade2p activity to yield white
colonies. Of these, eight were isolated from the random
screens in which an equal number (200) of white and
pigmented colonies were examined, and 11 were alter-
ations to positions 1, 2 or 15. Mutations that substantially
decreased 2A activity were identiﬁed at nearly all other
positions of 2A, and included several conservative
changes (e.g. Leu7 and Leu9 to Val). The exception was
position 8, where all of the ﬁve changes examined yielded
white or pale pink colonies. The only change to a
conserved position of 2A that retained relatively high
activity was Gln14 to Glu, which yielded pale pink
colonies, and this conﬁrmed previous results (3).
Comparison of 2A peptide sequences
Previous analysis of 2A peptides has indicated that they
comprise a conserved C-terminal motif, -D12(V/I)
ExNPG+P19- (3,4) and a non-conserved N-terminal
portion. The ﬁnding that many changes to non-conserved
as well as conserved amino acids within 2A led to signiﬁ-
cant loss of activity (Figures 1–3) was then somewhat
surprising, given that conservation typically correlates
with functional importance. The number of 2A peptides
identiﬁed in viral genomes has increased in recent years
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Figure 2. The [UBI-R2A-ADE2] artiﬁcial polyprotein reporter.
(A) [UBI-R2A-ADE2] comprises ubiquitin and S. cerevisiae Ade2p
separated by a single arginine, a 4 amino acid linker (GACG) and
FMDV 2A. The separation point of the nascent chain driven by the 2A
reaction is indicated with a downwards arrow. (B) [UBI-R2A-ADE2]
containing wild-type 2A or the non-functional Pro17 to Ala mutant
(3) were expressed in ade2 yeast strains that were either contained
(wild type), or lacked (ubr1D), and streaked on plates containing
limited (left) or no (right) adenine as indicated (C) ade2 yeast express-
ing [UBI-R2A-ADE2] containing 2A mutants as indicated were spotted
onto plates containing limited amounts of adenine. The previously
determined activity of each mutant in in vitro translations (3) is
indicated. (D) ade2 yeast expressing [UBI-2A-ADE2], Gly- or
Pro-substitution mutants or an empty vector as indicated in the table
below were assayed by spotting suspensions of the cells onto plates
containing limited amounts of adenine. Images of plates were
captured using an Epson scanner, imported into and cropped in
Photoshop. In (B–D) wild-type 2A is designated WT, and mutants by
the numerical position in 2A and the single letter code for the amino
acid replacing the wild type at that position. V is an empty vector
control. Plates were incubated for 3 days at 30 C.
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able was made to determine whether this might aid inter-
pretation of the mutagenesis data (Figure 4A and B and
Supplementary Table S1). It should be noted that while
the activity of many of these have been conﬁrmed in
reporter proteins (indicated in Supplementary Table S1),
others have not been tested, and are thus currently putative
2As. This analysis conﬁrmed the previous consensus, and
highlighted position 11 as also being conserved. Gly is
present at position 11 in 41 of the 52 sequences, and His
in all but three of the remainder. Within the N-terminal
portion of 2As, Leu is the most frequent amino acid at
positions 6–9, while Gly, Pro and aromatic amino acids
are excluded from positions 6–10 [a single exception being
Phe6 in Ljungan virus (LV)]. The ﬁrst ﬁve amino acids of
2A are extremely variable. However, these, and amino
acids upstream of 2A itself, enhance reaction efﬁciency
(3,4,19). Features, not readily identiﬁable from the
primary sequence, must then be included in (or excluded
from) this region for it to stimulate 2A function.
A
B
C
D
Figure 4. Sequence variation within 2A peptides. (A) Amino acids present at each position within 2A are shown in a cone plot, with height of cones
corresponding to the number of times each amino acid is present at this position in the 52 2A peptides in the data set (sequences are in
Supplementary Table S1). Amino acids are coloured according to the standard Rasmol amino colour scheme, and grouped by chemical property.
(B–D) Conservation within 2A peptides is shown as Weblogo representations. Each stack of letters corresponds to one position within the sequence,
with the height of each stack indicating the conservation at that position and the height of letters within the stack the frequency at which the
corresponding amino acid is found. Separate Weblogos are shown for (B) the full set of 52 2A peptides (C) Picornaviral peptides with Gly at position
11 (17 sequences) and (D) Picornaviral peptides with His at position 11 (eight sequences).
Figure 3. 2A is intolerant to mutation at most positions. The FMDV 2A sequence is shown, with, underneath, single amino acid changes isolated at
each position in random screens or generated through site-directed mutagenesis and which were assessed in vivo using [UBI-R2A-ADE2]. Changes
that correspond to amino acids found in other 2A peptides are underlined. Activity was assessed from colour of colonies after growth on plates
containing limiting adenine (as in Figure 2) and divided into four categories: white (as with wild-type 2A), pale pink, dark pink and red (as cells
lacking ADE2 or expressing the Pro17 to Ala mutant of [UBI-R2A-ADE2]). Within each category, the order of amino acids does not reﬂect relative
activity, but is as they appear in the list to the right.
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Amongst the mutations that inactivated FMDV 2A were
all those at position 11, including substitution with His
(Figure 4). This was intriguing because, as noted above,
His is the most common amino acid at this position after
Gly. His11 is found almost exclusively in cardioviral 2A
peptides, the sole exception being a human cosaviral 2A
(HCoSV-B1). Comparison of this sub-set of sequences
with other Picornaviral 2As (containing Gly11) revealed
a very different composition in the N-terminal portions
(compare Figure 4C and D and see Supplementary
Table S1). Thus, Ala2, Tyr4 and Leu9 are present in all
available His11-containing 2A sequences. In addition, Ile,
Met or Gln is found at position 10 and Gln or Asp is only
found at positions 7 of His11-containing, but not in
Gly11-containing, 2A peptides. This suggests that very
different constraints may exist on 2A sequence when
His, rather than Gly, is present at position 11. More
globally, this suggests that the sequence of the
non-conserved portion of each distinct 2A may be a
speciﬁc solution to the problem of allowing the conserved
motif to drive the 2A reaction, rather than particular
amino acid(s) being possible at each position independent
of others.
Inactivity of the FMDV 2A containing His11 provided
a means to test this hypothesis. EMCV and TMEV, which
both contain His11, are active in [CFP-2A-PAC] and
other artiﬁcial polyproteins [Table 1; (3,19)]. However,
fusions between sequences encoding FMDV 2A and
either EMCV or TMEV 2A peptides that altered
position 11 with respect to upstream amino acids had
similar, low, activity to the FMDV 2A His11 mutant
(Table 1, mutants E9/10F, F9/10E, T9/10F, T10/11F
and F9/10T).
In further tests, changes were made to FMDV 2A
alongside the Gly11 to His mutation, introducing either
single or groups of amino acids found in His11-containing
2A peptides (Table 1). None of the mutations tested,
including replacing amino acids 4–7 with the sequence
YYKQ (mutant FMDV(F4Y,D5Y,L6K,L7Q,G11H)) found in
the majority of His11 containing 2A peptides
(Supplementary Table S1 and Figure 4D), produced sig-
niﬁcant activity in combination with His at position 11.
Indeed, many of the additional mutations further
decreased the activity of the FMDV 2A Gly11 to His
mutant. The mutations tested were not an exhaustive
set, but these data suggest that the negative effect of
changing position 11 from Gly to His within FMDV 2A
cannot be compensated for by other small changes within
the peptide, and is consistent with the proposal that
speciﬁc combinations of amino acids throughout the
N-terminal portion of 2A enable it to function.
2A affects ribosomal ability to carry out termination at a
stop codon
Nascent 2A peptide-exit tunnel interactions promote
translation termination over Gly18-Pro19 peptide bond
formation as the ﬁrst step in the 2A reaction (6). As an
extension of the analysis of (sense) mutations to 2A, a
variant of [CFP-2A-PAC] containing a stop codon in
place of Pro19 was generated and analysed in vitro. This
tested whether release factors could interpret a stop codon
and catalyse termination in the context of the peptidyl
2A–ribosome complex. This revealed, on neutral pH
SDS–PAGE gels (NuPage; Invitrogen) that retain
peptidyl–tRNA ester bonds, a species  20kDa larger
than that of the [CFP-2A] product. Consistent with this
representing a peptidyl–tRNA adduct, its mobility
increased to the expected size on treatment with RNAse
(Figure 5A). A similar-sized, RNAse-sensitive product
was also seen, though faintly, in translation reactions
programmed with RNA containing a Gly18 to stop
mutant, but not reactions programmed with a Pro17 to
stop mutant nor a Pro17 to Ala, Pro19 to stop double
mutant.
A second set of templates were used to conﬁrm this
result (Figure 5B). In these, sequences upstream of those
encoding 2A were derived from yeast alpha factor rather
than CFP, and they were truncated to leave sequences
encoding 2A at their 30 ends. Translation of truncated
RNAs without stop codons leads to ribosome stalling,
with nascent chains remaining tRNA associated. This
was seen for the RNA that extended to the end of 2A,
but included the inactivating Pro17 to Ala mutation, an
RNAse-sensitive product larger than the free polypeptide
accumulating in translation reactions programmed with
this RNA. In contrast, and as seen previously (6), on
translation of a template ending in wild-type 2A, the
nascent peptide was released from tRNA due to the 2A
reaction. When the RNA ended at position 17 of 2A, but
Table 1. 2A peptides are ﬁne-tuned to function as a whole
2A peptide/
mutant
Sequence Activity
(%)
SD
(±) 51 01 51 9
FMDV LLNFDLLKLAGDVESNPGP 73.5 9
EMCV YAGYFADLLIHDIETNPGP 94.0 0.74
TMEV HADYYKQRLIHDVETNPGP 60.7 6.8
E9/10F YAGYFADLLAGDVESNPGP 15.0 2.9
F9/10E LLNFDLLKLIHDIETNPGP 18.2 4.4
T9/10F HADYYKQRLAGDVESNPGP 9.9 2.7
T10/11F HADYYKQRLIGDVESNPGP 11.9 3.3
F9/10T LLNFDLLKLIHDVETNPGP 14.5 1.1
FMDV(G11H) LLNFDLLKLAHDVESNPGP 9.1 2.7
FMDV(A10I) LLNFDLLKLIGDVESNPGP 5.5 7.3
FMDV(A10I,G11H) LLNFDLLKLIHDVESNPGP 6.2 2.8
FMDV(L6K) LLNFDKLKLAGDVESNPGP 33.2 2.7
FMDV(L6K,G11H) LLNFDKLKLAHDVESNPGP 1.3 2.2
FMDV(L7Q) LLNFDLQKLAGDVESNPGP 2.5 1.8
FMDV(L7Q,G11H) LLNFDLQKLAHDVESNPGP 3.1 0.9
FMDV(L7D) LLNFDLDKLAGDVESNPGP 0.9 1.5
FMDV(L7D,G11H) LLNFDLDKLAHDVESNPGP 3.1 3.1
FMDV(L6K,L7Q,G11H) LLNFDKQKLAHDVESNPGP 1.2 2.4
FMDV(F4Y,D5Y,L6K,
L7Q,G11H)
LLNYYKQKLAHDVESNPGP 0.2 0.3
Coupled transcription–translation reactions were carried out and
analysed as in Figure 1 for the 2A peptides and mutants indicated.
Activity is the percentage of ribosomes releasing the upstream product
from three or more independent samples and±1 SD is shown.
EMCV sequence is highlighted in pale grey, TMEV in dark grey.
Fusions between peptides are denoted by the ﬁrst letter of the virus
from which each portion originates, with numbers between them cor-
responding to the fusion junction.
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peptide was also efﬁciently released from tRNA, the
stop codon functioning normally. However, translation
of templates extending to position 18 or 19 of 2A, but
with the Gly18 or Pro19 codon in each case replaced by
a stop codon, led to strong accumulation of RNAse-
sensitive peptidyl-tRNA adducts. This occurred on
translation of templates ending at position 19 irrespective
of which of the three stop codons was substituted for
Pro19 (Figure 5C). Failure to release the nascent peptide
from templates containing a stop codon instead of Pro19
was due to the presence of the otherwise wild-type 2A
peptide sequence since the peptide was released on trans-
lation of a template containing both the Pro17 to Ala and
Pro19 to stop mutations.
Data obtained from in vitro translation of the two sets
of templates are consistent with a stop codon being poorly
functional at position 19 of 2A, and the Gly18 to stop
mutant peptide also being inefﬁciently released from ribo-
somes, particularly in the absence of further 30 nucleotides.
This provides evidence for 2A altering ribosomal structure
and/or function, and further indicates that this is (partly)
manifested one elongation cycle ahead of the position at
which the 2A reaction takes place.
DISCUSSION
The 2A reaction co-translationally resolves what
would otherwise be a continuous polypeptide chain into
two, between the ﬁnal Gly and Pro amino acids of
2A. The presence of functional 2A peptides in a wide
variety of virus polyproteins indicates that they contribute
signiﬁcantly to viral gene expression. This is exempliﬁed in
EMCV, where inactivation of 2A results in loss of viability
(11). Here, variability in naturally occurring viral
2A peptide sequences has been examined, and systematic
mutagenesis of the FMDV 2A peptide performed. This
was complemented with random screens for mutants and
generation of fusions between 2A peptides with differing
sequence compositions. Further, it was found that the 2A–
ribosome interaction, in addition to preventing addition of
Pro19 to the nascent chain, impedes the ability of eRFs to
release the nascent chain when a stop replaced either
Pro19 or Gly18 codon. This contrasts starkly with the
normal 2A reaction in which eRFs release the nascent
chain, and provides further strong evidence for 2A
driving alteration to ribosomal conformation.
Mutations to 2A may increase or decrease the efﬁciency
of the 2A reaction, alter the ratio of upstream to down-
stream product or, as seen with the Pro19 to stop mutants,
impair release of the upstream product. FMDV 2A was
 70% efﬁcient in the context of [CFP-2A-PAC], and thus
increased reaction efﬁciency, as seen with EMCV 2A,
could be revealed with this reporter (Table 1). However,
none of the FMDV 2A mutants generated and examined
in [CFP-2A-PAC] in this study increased its efﬁciency.
Neither did any lead to signiﬁcant alteration of the
[CFP-2A]:PAC translation product ratio.
The [UBI-R2A-ADE2] reporter (Figure 2) facilitated
rapid screening of randomly mutated 2A for effects on
its activity. With regard to quantiﬁcation of translational
outcomes, the in vivo assay possessed a reduced dynamic
range compared to in vitro translation. Thus, 2A mutants
that yielded 50% or greater activity in vitro also yielded
white colonies in vivo (e.g. Ala at position 15, Gly at pos-
itions 1 or 2). The amount of (stable) Ade2p generated
from these mutants was still sufﬁcient to saturate
A
B
C
Figure 5. Replacement of G18 or P19 in FMDV 2A with a stop codon
stalls ribosomes and impairs yeast growth. (A) Coupled in vitro tran-
scription–translation reactions assembled in reticulocyte lysate with
[35-S] methionine and indicated variants of [CFP-2A-PAC] were
resolved on a Nu-PAGE (Invitrogen) SDS–PAGE gel and visualized
using a phosphorimager. Full-length translation product (E), separated
upstream, [CFP-2A] (up) and downstream PAC (down) products and
the RNAse-sensitive peptidyl 2A-tRNA adduct (asterisks) are
indicated. X indicates a stop codon (B and C) In vitro translation
reactions assembled in wheat germ lysate with [35-S] methionine and
programmed with truncated RNAs encoding abbreviated yeast
pro-a-factor followed by 2A were analysed and labelled as in (A),
except that here ‘up’ refers to [aF-2A] and in these experiments the
RNA ended at the last codon indicated. Nucleotides of the three stop
codons used to replace the Pro19 codon in (C) are indicated. Except for
the two lanes in the right hand panel of (B), all samples were divided
into two equal portions and one treated with RNAse A as indicated
prior to loading. M, markers in kDa.
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activity scale, mutants with 20% activity or less in
[CFP-2A-PAC] yielded red colonies with [UBI-
R2A-ADE2]. In very few cases, the two assays gave dif-
fering readouts. The Asn3 to Gly mutant yielded white
colonies, but only 35% activity in vitro, while Glu5 to
Ala yielded dark pink colonies yet had  45% activity
in vitro. These differences possibly relate to differences in
the ribosomes (rabbit or yeast) synthesizing the peptide.
A limitation to [UBI-R2A-ADE2] is that it does not dis-
criminate complete failure of the 2A reaction from
decrease in synthesis of the downstream product.
However, as noted above, no mutants were identiﬁed
out of those tested in the [CFP-2A-PAC] reporter that
altered the ratio of [CFP-2A]:PAC. Such mutations may
then be rare.
The major conclusion from the FMDV 2A mutagenesis
experiments is that it is largely intolerant to amino acid
substitution over most of its length. This is highlighted by
the fact that in the in vivo screen for 2A mutants only 8 of
200 white colonies picked contained mutations that
altered the peptide sequence. While mutations of
conserved amino acids have, in general, more pronounced
effects than changes to non-conserved ones [Figures 1–3;
(3)], alteration to several non-conserved positions (and
particularly 7, 9 and 10) also yielded signiﬁcant reduction,
and in some cases complete loss of, activity. Substitutions
at only two internal positions, 8 and 15, retained high
activity (Figure 3). This differs to that observed in other
peptides known to affect ribosomal activity such as secM,
ermC and the arginine attenuator peptide, where muta-
tions to a small number of critical amino acids have sig-
niﬁcant effects on activity (20–22). This supports the
conclusion that the FMDV 2A, and by inference other
2A peptides, is optimized over its entire length to deliver
the exacting requirements for translational recoding.
Failure to generate ‘hybrid’ peptides with signiﬁcant
activity when the N- and C-terminal portions of FMDV,
TMEV and EMCV 2A were swapped highlights the func-
tional integration of each peptide (Table 1). The experi-
ments carried out here tested 2A recoding activity, but it is
worth noting that, at least for some 2A peptides, there
may be other constraints on sequence in the context of
the virus. This is highlighted by the identiﬁcation of a
mutation to the conserved portion of EMCV 2A that
retains activity, but impedes subsequent proteolytic pro-
cessing (11).
Picornaviral 2A peptides have been suggested to adopt
an a-helical conformation within the exit tunnel over
much of their length, with a reverse turn at the
C-terminus (5,10,23). Although not necessarily inform-
ative in terms of the environment of the ribosomal exit
tunnel, modelling of 2A peptides reveals that high
a-helical propensity is not a universal feature within the
2A peptides examined here (data not shown). The differ-
ent properties of Ala, Gly and Pro made it reasonable to
expect that substitution of individual 2A amino acids
within them may have different effects. However, these
substitutions had, in general, similar effects, suggesting
amino acid identity at most positions within the peptide
is of primary importance, rather than any structural
changes that the amino acid substitutions may impose
on the peptide. An exception was position 15, where
mutation of Ser15 to Gly impaired function more than
Ala or Pro substitutions, suggesting that increased
backbone ﬂexibility conferred by Gly at this position
was particularly detrimental. Until structural data of ribo-
somes with 2A peptides in situ are available, the conform-
ation of the complex remains obscure. Structural data are,
however, available for a number of other ribosome–
nascent peptide complexes, both prokaryotic and eukary-
otic, including some containing ‘stalling’ peptides (24–26).
Several of these structures reveal stalling peptides in
extended conformation in the exit tunnel. A cryo-EM
structure of ribosomes containing the arginine attenuator
peptide contains density close to the PTC consistent with a
compact conformation of this portion of the peptide (25).
Mutants examined here increase the range of amino
acid substitutions made to P19, the list extending to Gly,
Leu, Lys, The, Ala, Glu, Arg, Ser, Ile and Phe Figures 2
and 3 (3,10)]. All these lead to loss or almost complete loss
of activity. While not an exhaustive list, this supports the
notion that the constrained amino group within the pyr-
rolidine ring of proline is key to the 2A reaction, and that
ribosomal conformation is subtly altered by interactions
with the nascent 2A peptide to speciﬁcally inhibit its in-
corporation into the nascent chain (5,27).
Further support for alteration to ribosomal conform-
ation being at the heart of the 2A reaction comes from
the remarkable observation that a stop codon at position
19 functions very poorly (Figure 4A and B). The inability
to release the nascent chain in 2A containing a stop codon
at position 19 contrasts starkly with translation of
wild-type 2A where eRFs catalyse release of the nascent
chain on the Pro19 codon. An interpretation of these data
is that, analogous to the inability of prolyl-tRNA
Pro to
decode a proline codon and incorporate proline into the
nascent chain in wild type 2A, eRF1 recognizes the stop
codon at position 19, but is then unable to engage pro-
ductively with the PTC to catalyse hydrolysis of the
peptidyl–tRNA
Gly ester linkage.
2A initiates changes to ribosomal conformation before
the Pro19 codon reaches the ribosomal A-site, since tem-
plates including the Gly18 to stop mutant also lead to
accumulation of peptidyl(2A)–tRNA adducts when the
RNA ended at this point (Figure 4A). Since such
adducts were seen at a much lower level when the RNA
extended beyond 2A, mRNA beyond the A-site within the
entry channel may oppose the effect of the 2A nascent
chain in the exit tunnel until the Pro19 codon reaches
the A-site.
In addition to 2A, stalling of ribosomes with a stop
codon in the PTC is driven by several other peptides
including the bacterial TnaC leader, cytomegalovirus
UL4 gene uORF2 and fungal AAP. In each of the
TnaC–uORF2- and AAP–ribosome complexes, the inter-
action of the peptide with the ribosome results in changes
to the conformation of the PTC that are suggested to
prevent release factor activity (24,25). Given that
wild-type 2A ‘promotes’ release factor action, an expect-
ation would be that the PTC of ribosomes at 2A is not
distorted to impede termination activity.
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